Domestic hospital EBITDA surged 40% in Q1 FY27, driven by high-end procedures and increased footfalls, maintaining 24% margins.

Management expects continued margin expansion and is deploying INR 3,000 Cr for expansion, including a new 100-bed facility by Q2 end.

While India clinics posted an INR 15 Cr loss and UK operations saw higher losses due to a heatwave, Cayman insurance losses narrowed to USD 3.7 million with strong renewals.

The integrated care model remains central, with focus on cost control and diversifying UK's payer mix from NHS.

Management is confident in long-term growth.